Clinical Radiology
Volume 63, Issue 7 , Pages 739-743 , July 2008

Precautions to be taken by radiologists and radiographers when prescribing hyoscine-N-butylbromide

  • R. Dyde

      Affiliations

    • Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
    • ,
  • A.H. Chapman

      Affiliations

    • Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
    • Corresponding Author InformationGuarantor and correspondent: A.H. Chapman, Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds LS8 1 EW, UK. Tel.: +44 113 2065596; fax: +44 113 2064691.
    • ,
  • R. Gale

      Affiliations

    • Department of Opthalmology, University of Leeds, Leeds, UK
    • ,
  • A. Mackintosh

      Affiliations

    • Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
    • ,
  • D.J.M. Tolan

      Affiliations

    • Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Received 11 December 2007 ,Revised 20 February 2008 ,Accepted 22 February 2008.

References 

  1. Goei R, Nix M, Kessels AH, et al. Use of antispasmodic drugs in double contrast barium enema examination: glucagon or buscopan?. Clin Radiol. 1995;50:553–557
  2. Johnson W, Taylor MB, Carrington BM, et al. The value of hyoscine butylbromide in pelvic MRI. Clin Radiol. 2007;62:1087–1093
  3. Kozak RI, Bennett JD, Brown TC, et al. Reduction of bowel motion artifact during digital subtraction angiography: a comparison of hyoscine butylbromide and glucagon. Can Assoc Radiol J. 1994;45:209–211
  4. Shutt LE, Bowes JB. Atropine and hyoscine. Anaesthesia. 1979;34:476–490
  5. Roach SC, Martin OJ, Owen A, et al. Blood pressure changes during barium enema. Clin Radiol. 2001;56:393–396
  6. Cittadini G, Sardanelli F, De Cicco E, et al. Compared effect of a genetically engineered glucagon and hyoscine N-butylbromide on double-contrast barium meal study. Eur Radiol. 1998;8:449–453
  7. Herxheimer A, Lisette H. Human pharmacology of hyoscine butylbromide. Lancet. 1966;20:418–421
  8. Guignard JP, Herxheimer A, Greenwood RM. Effects of hyoscine butylbromide on gut motility. Clin Pharmacol Ther. 1968;9:745–748
  9. Blakeborough A, Sheridan MB, Chapman AH. Complications of barium enema examinations: a survey of UK consultant radiologists 1992 to 1994. Clin Radiol. 1997;52:142–148
  10. Higgins CB, Roeske WR, Karliner JS, et al. Predictive factors and mechanism of arrhythmias and myocardial ischaemic changes in elderly patients during barium enema. Br J Radiol. 1976;49:1023–1027
  11. Roeske WR, Higgins C, Karliner JS, et al. Incidence of arrhythmias and ST-segment changes in elderly patients during barium enema studies. Am Heart J. 1975;90:688–694
  12. Eastwood GL. ECG abnormalities associated with the barium enema. JAMA. 1972;219:719–721
  13. Maher R, Phillips-Hughes J, Banning A, et al. The frequency and significance of silent myocardial ischemia due to hyoscine butylbromide use in peripheral angiography. Cardiovasc Intervent Radiol. 1999;22:369–374
  14. Christensen M, Reinert R, Rasmussen V, et al. Factors that affect the variability in heart rate during endoscopic retrograde cholangiopancreatography. Eur J Surg. 2002;168:546–551
  15. Cox AR, Marriott JF, Wilson KA, et al. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther. 2004;29:31–35
  16. Cevese A, Mary DA, Poltronieri R, et al. Efferent limb of the coronary vasoconstrictor reflex elicited by distension of the descending colon in anesthetized dogs. Cardioscience. 1992;3:35–40
  17. Katoh K, Nomura M, Iga A, et al. Comparison of gastric peristalsis inhibition by scopolamine butylbromide and glucagon: evaluation by electrogastrography and analysis of heart rate variability. J Gastroenterol. 2003;38:629–635
  18. Dhein S, Van Koppen CJ, Brodde O-E. Muscarinic receptors in the mammalian heart. Pharmacol Res. 2001;44:161–182
  19. Taylor SA, Halligan S, Goh V, et al. Optimizing colonic distention for multi-detector row CT colonography: effect of hyoscine butylbromide and rectal balloon catheter. Radiology. 2003;229:99–108
  20. Mui LM, Ng EK, Chan KC, et al. Randomized, double-blinded, placebo-controlled trial of intravenously administered hyoscine N-butyl bromide in patients undergoing colonoscopy with patient-controlled sedation. Gastrointest Endosc. 2004;59:22–27
  21. Kleiger RE, Miller JP, Bigger JTJ, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256–262
  22. Vaughan D, Riordan-Eva P. Glaucoma. In:  Vaughan D,  Asbury T,  Riordan-Eva P editor. General ophthalmology. 15th ed.. Stamford, CT: Appleton & Lange; 1999;p. 200–215
  23. Fink AM, Aylward GW. Buscopan and glaucoma: a survey of current practice. Clin Radiol. 1995;50:160–164
  24. Sissons GRJ, McQueenie A, Mantle M. The ocular effects of Buscopan. Br J Radiol. 1991;64:584–586
  25. Mehlfeld G, Bleichert A. The effect of anticholinergic drugs on the inner eye muscles. Graefes Arch Clin Exp Ophthalmol. 1986;224:92–95

PII: S0009-9260(08)00119-0

doi: 10.1016/j.crad.2008.02.008

Clinical Radiology
Volume 63, Issue 7 , Pages 739-743 , July 2008

Article Tools